CHPA Statement on OTC Benefits Research

The following is a statement from the Consumer Healthcare Products Association in response to a recent study by Northwestern University on the benefits of using over-the-counter medicines to treat viral upper respiratory infections:

Washington, D.C. (October 26, 2004)—The Consumer Healthcare Products Association (CHPA) commends recent research highlighting the tremendous value of over-the-counter (OTC) medicines to the healthcare system and economy alike. A study released today by Northwestern University and commissioned by CHPA shows that using OTCs to treat certain upper respiratory infections may save $4.75 billion annually.

The research further demonstrates the increasingly vital role OTCs play in the U.S. healthcare system. Millions of Americans rely on safe and effective nonprescription medicines every day. This study shows that not only do these consumers receive relief from their cold and flu symptoms, the U.S. economy and healthcare system also receive relief from lost worker productivity, unnecessary physician visits, and taking prescription drugs when inappropriate.

To view the press release from Northwestern University about the study, click here.

For background information about the study and its findings, click here.

Contacts: Virginia Cox and Mimi Pappas, 202.429.9260

CHPA is the 123-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and nutritional supplement products.